Financial intelligence for Asia's healthcare markets
Remember me:

Australia: Moelis takes 10% stake in Japara

Investment bank Moelis Australia has acquired a 10% stake in care operator Japara Healthcare for A$67.9 million (US$53.1 million).

Investment funds managed by Moelis Australia Asset Management have acquired a $50.4 million strategic interest in Japara inclusive of a $17.5 million investment by Moelis Australia.

“Moelis Australia believes that aged care is an attractive sector in which to invest and that Japara has quality assets combined with an outstanding record of management, governance and provision of resident care,” it said.

The move follows Moelis’ acquisition of a 70% controlling stake in care operator Infinite Care from Next Capital for A$45.4 million at the end of September.

Infinite Care has five aged home care facilities in operation in Adelaide as well as two new greenfield sites under development in Toowoomba and Cornubia in South East Queensland which are due for completion in 2018. It has a development pipeline of 1,500 bed licenses across 13 to be developed facilities in areas of aged care undersupply. Founders and joint managing directors of Infinite Care, Chris Stride and Tony Partridge will continue to run the business.

When the acquisition completes at the end of the month, Moelis Australia will hold its interest in Infinite Care via a newly established managed fund, the Moelis Australia Aged Care Fund. Moelis Australia will offer third party investors the opportunity to co-invest in the Fund with Moelis Australia retaining a co-investment stake of 10%.

The fund, which has now been upsized to A$70 million, is targeting a total return of more than 20% a year over a four year term.

Shares in Japara yesterday jumped 7.5% to A$2.00.

Posted on: 25/10/2017 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.